Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

300 results about "Lag time" patented technology

Method and apparatus for exchanging event information between computer systems that reduce perceived lag times by subtracting actual lag times from event playback time

Mechanisms and techniques provide the system that allows a sending computer system to capture and store event information related to events that transpire on a sending computer system in event batches. The event information can include event functionality related to event object in the timestamp related to the event. Periodically, in response to the occurrence of the batch transfer condition, the sending computer system transmits an event batch monthly computer network for receipt by a receiving computer system. The event batch may be processed through a collaboration adapter on the networks while prior to being send to the receiving computer system. Upon receipt of an event batch at the receiving computer system, the receiving computer system can compute a lag time required to receive the event batch. The receiving computer system can then recreate events based on the event information in the event batches while compensating for network lag time incurred during transmission of the event batch between a sending and receiving computer systems. By compensating for network lag during the recreation or playback of events, the system of the invention avoids the receiving computer system from reproducing events in a choppy or discontinuous manner or from getting left behind during event recreation due to accumulations of network lag time.
Owner:CISCO TECH INC

Controlled release preparation

The invention discloses a controlled release preparation with improved performance. The controlled release preparation comprises a core containing medicament and a controlled release film covering the outside of the core and being almost insoluble in water as well as stomach and intestines digestive juice. The controlled release film comprises particulate matters of a water soluble medicinal additive, the water-soluble medicinal additive is covered by a polymer film which can be soluble in the stomach and/or intestines digestive juice but almost insoluble in water, the polymer and the medicinal additive can not produce chemical reaction or can produce chemical reaction but do not produce water-insoluble non-gaseous products and the pharmaceutically unacceptable products, and the amount of the polymer is no more 700% of that of the medicinal additive. The invention also discloses a preparation method of the controlled release preparation. The controlled release preparation has the advantages of improved medicament release reproducibility, reduced medicament release lag time, accelerated medicament release and improved bioavailability, can realize located controlled release, delayed controlled release and interval type or pulse type controlled release of the medicament in the gastrointestinal tract, and the like.
Owner:钟术光

Modified release compositions of milnacipran

A once-a-day oral milnacipran modified release formulation has been developed. The formulation comprises an extended release dosage unit (optionally containing the immediate release portion) coated with delayed release coating. The milnacipran composition, when administered orally, first passes through the stomach releasing from zero to less than 10% of the total milnacipran dose and then enters the intestines where drug is released slowly over an extended period of time. The release profile is characterized by a 0.05-4 hours lag time period during which less than 10% of the total milnacipran dose is released followed by a slow or extended release of the remaining drug over a defined period of time. The composition provides in vivo drug plasma levels characterized by Tmax at 4-10 hours and an approximately linear drop-off thereafter and Cmax below 3000 ng / ml, preferably below 2000 ng / ml, and most preferably below 1000 ng / ml. The composition allows milnacipran to be delivered over approximately 24 hours, when administered to a patient in need, resulting in diminished incidence or decreased intensity of common milnacipran side effects such as sleep disturbance, nausea, vomiting, headache, tremulousness, anxiety, panic attacks, palpitations, urinary retention, orthostatic hypotension, diaphoresis, chest pain, rash, weight gain, back pain, constipation, vertigo, increased sweating, agitation, hot flushes, tremors, fatigue, somnolence, dyspepsia, dysoria, nervousness, dry mouth, abdominal pain, irritability, and insomnia.
Owner:COLLEGIUM PHARMA INC

Control method for electronic expansion valve, self-adaptive control method for heat pump, and device thereof

The invention discloses a control method for an electronic expansion valve, a self-adaptive control method for a heat pump, and a device thereof; wherein, the control method for the electronic expansion valve comprises the steps as follows: S110: the electronic expansion valve is started and initiated; a controller arranges the openness of the electronic expansion valve as an initial value; S120: after starting prearranged time, the controller determines the practical over-heat degree of the electronic expansion valve; S130: controller compares the practical over-heat degree with a destination over-heat degree so as to determine the optimum openness value domain of the electronic expansion valve, and S140: the controller adjusts the openness of the electronic expansion valve to the optimum openness value domain. Therefore, automatic regulation of refrigerant flux and throttling degree of the heat pump device according to the working conditions can be ensured, the system is protected and runs at a best state, the optimum openness of the electronic expansion valve can be quickly gained, the lag time is greatly reduced, and the throttling degree of the system can be adjusted according to the running state.
Owner:GREE ELECTRIC APPLIANCES INC

Robot joint tail end residual vibration restraining method based on input shaper

The invention discloses a robot joint tail end residual vibration restraining method based an input shaper. The robot joint tail end residual vibration restraining method based the input shaper comprises the steps that firstly, the undamped inherent frequency omega0 and the damping ratio zeta of a robot system are obtained; secondly, a linear programming problem mathematic model about the pulse amplitude parameter of the input shaper is established; thirdly, a pulse amplitude expression is solved through a lagrangian multiplier method, and the optimal solution of the pulse amplitude is workedout through iteration; fourthly, the optimal solution of the pulse amplitude and the pulse generation time are combined to form the control error optimization input shaper; and fifthly, a reference signal and the control error optimization input shaper are subjected to convolution operation, so that a novel shaping signal is obtained, and after a predicted path is planned for the novel shaping signal, the system is driven by the signal to restrain robot tail end residual vibration. According to the robot joint tail end residual vibration restraining method based the input shaper, the robustness of the input shaper is enhanced, and a process control error and a positioning error are minimized; and the predicted path is planned for the shaped signal, and thus the system lag time caused by input shaping is compensated and reduced.
Owner:SOUTH CHINA UNIV OF TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products